Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market 2026–2030: Emerging Trends and Forecast Opportunities
Uncover key drivers, emerging technologies, and competitive movements shaping the prostate-specific membrane antigen (psma) theranostic kits market from 2026–2035 with trusted insights from The Business Research Company
Starting from its 2026 valuation, what market size is the Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market expected to reach by 2030?
In recent years, the market for prostate-specific membrane antigen (psma) theranostic kits has seen substantial growth. This market is projected to expand from $1.05 billion in 2025 to $1.19 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 13.9%. Historically, this growth has been driven by factors such as the increasing prevalence of prostate cancer, progress in nuclear medicine imaging techniques, wider acceptance of molecular diagnostics, initial successful clinical validation of PSMA targeting strategies, and the broadening of oncology research initiatives.
The prostate-specific membrane antigen (psma) theranostic kits market is anticipated to experience substantial expansion in the coming years. By 2030, this market is projected to reach a valuation of $1.99 billion, demonstrating a compound annual growth rate (CAGR) of 13.5%. This growth can be attributed to several factors such as the increasing demand for personalized cancer treatments, rising investments in theranostics, the expansion of nuclear medicine infrastructure, the growing use of precision oncology diagnostics, and increasing regulatory approvals for targeted therapies. Major trends expected during this forecast period include the increasing adoption of targeted radioligand therapies, the rising use of psma-based precision diagnostics, the growing integration of imaging and therapy workflows, the expansion of personalized oncology treatment kits, and an enhanced focus on companion diagnostics.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=30362&type=smp
What Drivers Are Driving Adoption Within The Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market?
The increasing occurrence of prostate cancer is projected to stimulate the expansion of the prostate-specific membrane antigen (PSMA) theranostic kits market moving forward. Prostate cancer is defined as a form of malignancy that develops within the prostate gland, a small male gland located beneath the bladder and anterior to the rectum. The rising incidence of prostate cancer is attributable to the aging population, as the risk of acquiring this disease escalates significantly with age. Prostate-specific membrane antigen (PSMA) theranostic kits enhance prostate cancer management by delivering targeted diagnostic solutions, making them effective for early detection and personalized treatment planning. They improve the precision of diagnosis by combining PSMA-specific ligands with radiotracers, thereby supporting superior disease monitoring and treatment guidance. For instance, in November 2023, according to the American Cancer Society, a US-based non-profit organization, an estimated 313,780 new cases of prostate cancer and 35,770 deaths were anticipated in the United States in 2025. Hence, the growing incidence of prostate cancer is driving the growth of the prostate-specific membrane antigen (PSMA) theranostic kits market.
How Is The Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Organized Into Various Segments?
The prostate-specific membrane antigen (psma) theranostic kits market covered in this report is segmented –
1) By Product Type: Diagnostic Kits, Therapeutic Kits, Combined Theranostic Kits
2) By Application: Prostate Cancer, Other Cancers
3) By End-User: Hospitals, Diagnostic Centers, Research Institutes, Specialty Clinics, Other End-Users
Subsegments:
1) By Diagnostic Kits: Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography Imaging Kits, Single Photon Emission Computed Tomography Imaging Kits, Companion Diagnostic Kits, Liquid Biopsy Kits
2) By Therapeutic Kits: Radioligand Therapy Kits, Antibody-Based Therapy Kits, Peptide-Based Therapy Kits, Small Molecule Therapy Kits
3) By Combined Theranostic Kits: Integrated Imaging And Therapy Kits, Dual Function Radiopharmaceutical Kits, Prostate-Specific Membrane Antigen (PSMA) Ligand-Based Theranostic Kits, Personalized Treatment Kits
Which Innovation Trends Are Advancing Developments Within The Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market?
Leading companies operating in the prostate-specific membrane antigen (PSMA) theranostic kits market are concentrating on developing innovative solutions, such as PSMA-targeted radioligand kits, to address the increasing demand for precision oncology, targeted prostate cancer diagnosis, and treatment. PSMA-targeted radioligand kits are medical products that combine a ligand specifically designed to bind to Prostate-Specific Membrane Antigen (PSMA) with a radioactive isotope for diagnostic imaging or directed therapy of prostate cancer. For instance, in March 2025, Telix Pharmaceuticals Limited, an Australia-based radiopharmaceutical company, launched Illuccix, a novel kit for the preparation of Gallium-68 gozetotide injection. This kit allows hospitals and nuclear medicine facilities to label the radionuclide immediately before injection for PET imaging of PSMA-positive prostate cancer lesions. The kit’s unique features include a ready-to-use preparation format, disease-specific targeting, rapid imaging capability, and compatibility with theranostic workflows, facilitating improved detection of metastatic lesions, treatment planning, and monitoring therapy response. Its applications include the diagnosis of recurrent or metastatic prostate cancer and guiding personalized treatment decisions, marking a significant advancement over conventional imaging or non-targeted therapies.
Who Are The Core Companies Influencing Trends In The Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market?
Major companies operating in the prostate-specific membrane antigen (psma) theranostic kits market are Cyclotek (Aust) Pty Ltd, Telix Pharmaceuticals Ltd, Curium Pharma, SOFIE Biosciences Inc., Lantheus Holdings Inc., Eckert & Ziegler SE, NorthStar Medical Radioisotopes, Isotopia Molecular Imaging Ltd, ITM Isotope Technologies Munich SE, AdvanCell Pty Ltd, Alpha‑9 Theranostics Inc., ABX Advanced Biochemical Compounds GmbH, Clarity Pharmaceuticals Ltd, Ariceum Therapeutics GmbH, RadioMedix Inc., Scintomics GmbH, Novartis AG, Bayer AG, POINT Biopharma Inc., Blue Earth Diagnostics
Access The Complete Report For Deeper Market Insights:
Which Regions Are Projected To Dominate The Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market In The Coming Years?
North America was the largest region in the prostate-specific membrane antigen (PSMA) theranostic kits market in 2025. The regions covered in the prostate-specific membrane antigen (psma) theranostic kits market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=30362&type=smp
Browse Through More Reports Similar to the Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market 2026, By The Business Research Company
Prostate Cancer Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/prostate-cancer-drugs-global-market-report
Prostate Cancer Diagnostics Market Report 2026
https://www.thebusinessresearchcompany.com/report/prostate-cancer-diagnostics-global-market-report
Prostate Cancer Nuclear Medicine Diagnostics Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
